[PDF][PDF] Clinical epidemiology of cardiovascular disease in chronic renal disease

RN Foley, PS Parfrey, MJ Sarnak - American Journal of Kidney …, 1998 - academia.edu
● The risk of cardiovascular disease (CVD) in patients with chronic renal disease (CRD)
appears to be far greater than in the general population. For example, among patients treated …

Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular …

…, BL Kasiske, E Kelepouris, MJ Klag, P Parfrey… - Circulation, 2003 - Am Heart Assoc
Chronic kidney disease1 (CKD) is a worldwide public health problem. In the United States,
there is a rising incidence and prevalence of kidney failure, with poor outcomes and high cost…

[HTML][HTML] A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease

…, JB McGill, JJV McMurray, P Parfrey… - … England Journal of …, 2009 - Mass Medical Soc
Background Anemia is associated with an increased risk of cardiovascular and renal events
among patients with type 2 diabetes and chronic kidney disease. Although darbepoetin alfa …

Clinical and echocardiographic disease in patients starting end-stage renal disease therapy

RN Foley, PS Parfrey, JD Harnett, GM Kent, CJ Martin… - Kidney international, 1995 - Elsevier
… HARNEi-T JD, Ka'n GM, BARRE PE, TAYLOR R, PARFREY PS: Risk factors for the devlopment
of left ventricular hypertrophy in a prospectively followed cohort of dialysis patients. JAm …

Epidemiology of cardiovascular disease in chronic renal disease.

RN Foley, PS Parfrey, MJ Sarnak - Journal of the American Society …, 1998 - europepmc.org
The risk of cardiovascular disease in patients with chronic renal disease appears to be far
greater than in the general population. For example, among patients treated by hemodialysis …

Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both

PS Parfrey, SM Griffiths, BJ Barrett… - … England Journal of …, 1989 - Mass Medical Soc
To determine the risk of nephrotoxicity induced by the infusion of radiographic contrast
material, we undertook a prospective study of consecutive patients undergoing radiographic …

[HTML][HTML] Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency

…, MG Larson, PWF Wilson, JC Evans, PS Parfrey… - Kidney international, 1999 - Elsevier
Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency.
Background Little is known about the prevalence of cardiovascular disease (CVD) and …

The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease

RN Foley, PS Parfrey, JD Harnett, GM Kent… - American journal of …, 1996 - Elsevier
To determine the possible association between anemia and clinical and echocardiographic
cardiac disease, a cohort of 432 end-stage renal disease patients (261 on hemodialysis and …

Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors

…, RN Foley, GM Kent, PE Barre, D Murray, PS Parfrey - Kidney international, 1995 - Elsevier
PARFREY PS, HARNETF JD, GRIFFITH5 SM, GAULT MH, BARREN PE: Congestive heart
PARFREY PS, GRIFFITHS SM, HARNETF JD, TAYLOR R, KING A, HAND J, BARRE PE: …

The clinical epidemiology of cardiac disease in chronic renal failure

PS Parfrey, RN Foley - Journal of the American Society of …, 1999 - journals.lww.com
The annual mortality from cardiovascular disease in dialysis patients is substantially higher
than in the general population (Figure 1)(1). The 5-yr survival of men 64 yr old starting …